-
OCUL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ocular Therapeutix (OCUL)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 428.83 mm | 428.83 mm | 428.83 mm | 428.83 mm | 428.83 mm | 428.83 mm |
Cash burn (monthly) | 18.61 mm | (no burn) | 15.33 mm | 9.74 mm | 402.00 k | 5.44 mm |
Cash used (since last report) | 52.12 mm | n/a | 42.95 mm | 27.29 mm | 1.13 mm | 15.24 mm |
Cash remaining | 376.71 mm | n/a | 385.88 mm | 401.55 mm | 427.71 mm | 413.59 mm |
Runway (months of cash) | 20.2 | n/a | 25.2 | 41.2 | 1063.9 | 76.0 |
13F holders | Current |
---|---|
Total holders | 165 |
Opened positions | 35 |
Closed positions | 17 |
Increased positions | 41 |
Reduced positions | 48 |
13F shares | Current |
---|---|
Total value | 1.20 tn |
Total shares | 153.06 mm |
Total puts | 224.50 k |
Total calls | 149.60 k |
Total put/call ratio | 1.5 |
Largest owners | Shares | Value |
---|---|---|
Summer Road | 14.40 mm | $125.26 bn |
Venrock Healthcare Capital Partners III | 13.76 mm | $152.46 mm |
VR Adviser | 12.76 mm | $111.03 bn |
Deep Track Capital | 12.72 mm | $110.68 bn |
BlackRock | 11.35 mm | $98.78 bn |
Vanguard | 8.38 mm | $72.94 bn |
Avoro Capital Advisors | 8.06 mm | $70.12 bn |
TCG Crossover Management | 5.32 mm | $46.28 bn |
Opaleye Management | 5.03 mm | $43.72 bn |
Citadel Advisors | 4.26 mm | $37.06 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Nov 24 | Heier Jeffrey S. | Common Stock | Sell | Dispose S | No | No | 9.01 | 2,948 | 26.56 k | 269,059 |
25 Nov 24 | Peter Kaiser | Common Stock | Sell | Dispose S | No | No | 9.01 | 2,897 | 26.10 k | 213,087 |
25 Nov 24 | Sanjay Nayak | Common Stock | Sell | Dispose S | No | No | 9 | 1,814 | 16.33 k | 174,380 |
25 Nov 24 | Dugel Pravin | Common Stock | Sell | Dispose S | No | No | 9.01 | 20,680 | 186.33 k | 791,793 |